DE

Presentations & Videos

Presentations

Management Statement 9M 2024/25

IR Presentation May 2025

 

Archive presentations 2024/25

Management Statement 6M 2024/25

Management Statement 3M 2024/25

Management Statement 12M 2023/24

IR Presentation "Deutsches Eigenkapitalforum 2024"

Management Statement Akribion Therapeutics Agreement

Archive presentations 2023/24

Management Statement Royalty Purchase Agreement

IR Presentation "Baader Investment Conference 2024"

Management Statement 9M 2023/24

Management Statement 6M 2023/24

Videos

Financial Year 2024/25

BRAIN Biotech AG Deep Dive 2025 | AI-Driven Enzyme Discovery, U.S. Expansion, and Growth Strategy

Michael Schneiders, CFO of BRAIN Biotech AG, adresses the seven most frequently asked questions from institutional investors,  providing insights, perspectives, and a forward-looking outlook on topics ranging from AI-powered enzyme discovery and U.S. expansion to M&A strategy and the commercial pipeline within the BRAINBioIncubator portfolio.

BRAIN Biotech AG Financial Results 9M 2024 / 25

CFO Michael Schneiders: Strong Core Growth & BioIncubator Innovations

BRAIN Biotech AG Elevator Pitch 2025 | Strategy & Vision

Elevator Pitch from CFO Michael Schneiders
(Date of recording: June 4, 2025)

BRAIN Biotech AG Financial Results H1 2024/25

CFO Michael Schneiders: Financial Results H1 2024/25 | Innovation Momentum and Strategic Focus

BRAIN Biotech AG Financial Results Q1 2024/25

CFO Michael Schneiders: Financial Results Q1 2024/25 | Growth, Innovation & Outlook

Financial Year 2023/24

BRAIN Biotech AG Financial Results FY 2023/24

CFO Michael Schneiders: Financial Performance and Growth Strategy of BRAIN Biotech AG

All older videos can be found on the SEAT11a platform.

Contact